FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4291036130> ?p ?o ?g. }

• W4291036130 endingPage "6" @default.
• W4291036130 startingPage "1" @default.
• W4291036130 abstract "Objective. To investigate the serum levels of CXC chemokine 13 (CXCL-13), retinol binding protein-4 (RBP-4), and interleukin 6 (IL-6) in patients with Graves’ disease (GD). The correlation between CXCL-13, RBP-4, and IL-6 levels and the basal metabolic rate (BMR) was analyzed. Methods. 118 GD patients diagnosed in our hospital were selected as the observation group from March 2017 to December 2018. According to the measured BMR value, 118 GD patients were divided into the mild group (n = 39), the moderate group (n = 47), and the severe group (n = 32), three subgroups. 60 healthy subjects were selected as the control group. The serum levels of CXCL-13, RBP-4, IL-6, TSH, FT3, and FT4 in every group were measured. Pearson correlation analysis was used to observe the correlation of serum CXCL-13, RBP-4, and IL-6 levels with TSH, FT3, FT4, and BMR. Results. The levels of serum CXCL-13, RBP-4, and IL-6 in the observation group were higher than those of the control group, and the differences were statistically significant ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M1> <mi>P</mi> <mo><</mo> <mn>0.05</mn> </math> ). The levels of serum CXCL-13, RBP-4, and IL-6 in the moderate and severe groups were higher than those in the mild group, and the differences were statistically significant ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M2> <mi>P</mi> <mo><</mo> <mn>0.05</mn> </math> ). The levels of serum CXCL-13, RBP-4, and IL-6 in the severe group were higher than those in the moderate group, and the differences were statistically significant ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M3> <mi>P</mi> <mo><</mo> <mn>0.05</mn> </math> ). Pearson correlation analysis showed that the serum levels of CXCL-13, RBP-4, and IL-6 in GD patients were negatively correlated with TSH levels and positively correlated with FT3 and FT4 levels. Serum CXCL-13, RBP-4, and IL-6 levels in GD patients were positively correlated with BMR (r = 0.915, r = 0.942, r = 0.926, <math xmlns=http://www.w3.org/1998/Math/MathML id=M4> <mi>P</mi> <mo><</mo> <mn>0.001</mn> </math> ). Conclusion. Serum CXCL-13, RBP-4, and IL-6 levels are elevated in patients with GD, and with the aggravation of the disease, the serum CXCL-13, RBP-4, and IL-6 levels also increase, showing a positive correlation, which can be used as indicators to reflect the degree of GD." @default.
• W4291036130 created "2022-08-13" @default.
• W4291036130 creator A5010459180 @default.
• W4291036130 creator A5016826070 @default.
• W4291036130 creator A5031866678 @default.
• W4291036130 creator A5047576745 @default.
• W4291036130 creator A5081855564 @default.
• W4291036130 date "2022-08-12" @default.
• W4291036130 modified "2023-10-16" @default.
• W4291036130 title "Serum Levels of CXCL-13, RBP-4, and IL-6, and Correlation Analysis of Patients with Graves’ Disease" @default.
• W4291036130 cites W2510464317 @default.
• W4291036130 cites W2593091103 @default.
• W4291036130 cites W2593834856 @default.
• W4291036130 cites W2623719036 @default.
• W4291036130 cites W2850818478 @default.
• W4291036130 cites W2885376307 @default.
• W4291036130 cites W2901481339 @default.
• W4291036130 cites W2942803676 @default.
• W4291036130 cites W3001567918 @default.
• W4291036130 cites W3004634342 @default.
• W4291036130 cites W3004954461 @default.
• W4291036130 cites W3022601318 @default.
• W4291036130 cites W3036104064 @default.
• W4291036130 cites W3041618416 @default.
• W4291036130 cites W3042417625 @default.
• W4291036130 cites W3085560214 @default.
• W4291036130 cites W3095353411 @default.
• W4291036130 cites W3126204050 @default.
• W4291036130 cites W3127857646 @default.
• W4291036130 cites W3133822113 @default.
• W4291036130 cites W3134231389 @default.
• W4291036130 cites W3135190609 @default.
• W4291036130 cites W3210505472 @default.
• W4291036130 cites W4200194049 @default.
• W4291036130 doi "https://doi.org/10.1155/2022/5131846" @default.
• W4291036130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35990370" @default.
• W4291036130 hasPublicationYear "2022" @default.
• W4291036130 type Work @default.
• W4291036130 citedByCount "1" @default.
• W4291036130 crossrefType "journal-article" @default.
• W4291036130 hasAuthorship W4291036130A5010459180 @default.
• W4291036130 hasAuthorship W4291036130A5016826070 @default.
• W4291036130 hasAuthorship W4291036130A5031866678 @default.
• W4291036130 hasAuthorship W4291036130A5047576745 @default.
• W4291036130 hasAuthorship W4291036130A5081855564 @default.
• W4291036130 hasBestOaLocation W42910361301 @default.
• W4291036130 hasConcept C117220453 @default.
• W4291036130 hasConcept C126322002 @default.
• W4291036130 hasConcept C13373296 @default.
• W4291036130 hasConcept C134018914 @default.
• W4291036130 hasConcept C203014093 @default.
• W4291036130 hasConcept C2524010 @default.
• W4291036130 hasConcept C2776914184 @default.
• W4291036130 hasConcept C2776940978 @default.
• W4291036130 hasConcept C2778024521 @default.
• W4291036130 hasConcept C2779306644 @default.
• W4291036130 hasConcept C2779573558 @default.
• W4291036130 hasConcept C33923547 @default.
• W4291036130 hasConcept C71924100 @default.
• W4291036130 hasConcept C90924648 @default.
• W4291036130 hasConcept C97749175 @default.
• W4291036130 hasConceptScore W4291036130C117220453 @default.
• W4291036130 hasConceptScore W4291036130C126322002 @default.
• W4291036130 hasConceptScore W4291036130C13373296 @default.
• W4291036130 hasConceptScore W4291036130C134018914 @default.
• W4291036130 hasConceptScore W4291036130C203014093 @default.
• W4291036130 hasConceptScore W4291036130C2524010 @default.
• W4291036130 hasConceptScore W4291036130C2776914184 @default.
• W4291036130 hasConceptScore W4291036130C2776940978 @default.
• W4291036130 hasConceptScore W4291036130C2778024521 @default.
• W4291036130 hasConceptScore W4291036130C2779306644 @default.
• W4291036130 hasConceptScore W4291036130C2779573558 @default.
• W4291036130 hasConceptScore W4291036130C33923547 @default.
• W4291036130 hasConceptScore W4291036130C71924100 @default.
• W4291036130 hasConceptScore W4291036130C90924648 @default.
• W4291036130 hasConceptScore W4291036130C97749175 @default.
• W4291036130 hasLocation W42910361301 @default.
• W4291036130 hasLocation W42910361302 @default.
• W4291036130 hasLocation W42910361303 @default.
• W4291036130 hasOpenAccess W4291036130 @default.
• W4291036130 hasPrimaryLocation W42910361301 @default.
• W4291036130 hasRelatedWork W1969550954 @default.
• W4291036130 hasRelatedWork W2009854143 @default.
• W4291036130 hasRelatedWork W2016328345 @default.
• W4291036130 hasRelatedWork W2072392368 @default.
• W4291036130 hasRelatedWork W2077325982 @default.
• W4291036130 hasRelatedWork W2135024115 @default.
• W4291036130 hasRelatedWork W2150096959 @default.
• W4291036130 hasRelatedWork W2162653391 @default.
• W4291036130 hasRelatedWork W2411332413 @default.
• W4291036130 hasRelatedWork W2915913567 @default.
• W4291036130 hasVolume "2022" @default.
• W4291036130 isParatext "false" @default.
• W4291036130 isRetracted "false" @default.
• W4291036130 workType "article" @default.